73 related articles for article (PubMed ID: 35389123)
1. CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2/PI3K/AKT signaling pathway.
Jiang F; Wang MQ; Zhang MY; Gu SL; Xie YW; Huang Y; Zhou MY; Li FL; Yang YC; Zhang PP; Liu XS; Li R
Int Immunopharmacol; 2024 Apr; 131():111850. PubMed ID: 38479157
[TBL] [Abstract][Full Text] [Related]
2. A new look at angiogenesis inhibition of geniposide in experimental arthritis by blocking angiopoietin-2 exocytosis.
Gan P; Wu H; Zhu Y; Shu Y; Wei Y
Phytother Res; 2024 Mar; 38(3):1245-1261. PubMed ID: 38185885
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOTAIR regulates the PI3K/AKT pathway via the miR-126-3p/PIK3R2 axis to participate in synovial angiogenesis in rheumatoid arthritis.
Liu F; Wang Y; Huang D; Sun Y
Immun Inflamm Dis; 2023 Oct; 11(10):e1064. PubMed ID: 37904709
[TBL] [Abstract][Full Text] [Related]
4. Advances of the small molecule drugs regulating fibroblast-like synovial proliferation for rheumatoid arthritis.
Tong Y; Li X; Deng Q; Shi J; Feng Y; Bai L
Front Pharmacol; 2023; 14():1230293. PubMed ID: 37547337
[TBL] [Abstract][Full Text] [Related]
5. Natural medicines of targeted rheumatoid arthritis and its action mechanism.
Liu X; Wang Z; Qian H; Tao W; Zhang Y; Hu C; Mao W; Guo Q
Front Immunol; 2022; 13():945129. PubMed ID: 35979373
[TBL] [Abstract][Full Text] [Related]
6. Updated Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of Natural Product Geniposide.
Liu L; Wu Q; Chen Y; Gu G; Gao R; Peng B; Wang Y; Li A; Guo J; Xu X; Shao X; Li L; Shen Y; Sun J
Molecules; 2022 May; 27(10):. PubMed ID: 35630796
[TBL] [Abstract][Full Text] [Related]
7. PI3K/PTEN signaling in tumorigenesis and angiogenesis.
Jiang BH; Liu LZ
Biochim Biophys Acta; 2008 Jan; 1784(1):150-8. PubMed ID: 17964232
[TBL] [Abstract][Full Text] [Related]
8. PTEN: an emerging target in rheumatoid arthritis?
Zhou P; Meng X; Nie Z; Wang H; Wang K; Du A; Lei Y
Cell Commun Signal; 2024 Apr; 22(1):246. PubMed ID: 38671436
[TBL] [Abstract][Full Text] [Related]
9. The anti-angiogenesis mechanism of Geniposide on rheumatoid arthritis is related to the regulation of PTEN.
Bu Y; Wu H; Deng R; Wang Y
Inflammopharmacology; 2022 Jun; 30(3):1047-1062. PubMed ID: 35389123
[TBL] [Abstract][Full Text] [Related]
10. Geniposide restricts angiogenesis in experimentary arthritis via inhibiting Dnmt1-mediated PTEN hypermethylation.
Bu Y; Wu H; Deng R; Wang Y
Int Immunopharmacol; 2022 Oct; 111():109087. PubMed ID: 35908504
[TBL] [Abstract][Full Text] [Related]
11. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
[TBL] [Abstract][Full Text] [Related]
12. Matrine inhibits synovial angiogenesis in collagen-induced arthritis rats by regulating HIF-VEGF-Ang and inhibiting the PI3K/Akt signaling pathway.
Ao L; Gao H; Jia L; Liu S; Guo J; Liu B; Dong Q
Mol Immunol; 2022 Jan; 141():13-20. PubMed ID: 34781187
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
